|
1
|
Chan DN and So WK: A systematic review of
randomised controlled trials examining the effectiveness of breast
andcervical cancer screening interventions for ethnic minority
women. Eur J Oncol Nurs. 19:536–553. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maurer K, Luo H, Shen Z, Wang G, Du H,
Wang C, Liu X, Wang X, Qu X, Wu R and Belinson J: Evaluation of a
new solid media specimen transport card for high risk HPV detection
and cervical cancer prevention. J Clin Virol. 76:14–19. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qureshi R, Arora H, Biswas S, Perwez A,
Naseem A, Wajid S, Gandhi G and Rizvi MA: Mutation analysis of EGFR
and its correlation with the HPV in Indian cervical cancer
patients. Tumour Biol. 37:9089–9098. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chang H, Shi Y, Tuokan T, Chen R and Wang
X: Expression of aquaporin 8 and phosphorylation of Erk1/2 in
cervical epithelial carcinogenesis: Correlation with
clinicopathological parameters. Int J Clin Exp Pathol. 7:3928–3937.
2014.PubMed/NCBI
|
|
5
|
Asati V, Mahapatra DK and Bharti SK:
PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as
anticancer agents: Structural and pharmacological perspectives. Eur
J Med Chem. 109:314–341. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kake S, Usui T, Ohama T, Yamawaki H and
Sato K: Death-associated protein kinase 3 controls the tumor
progression of A549 cells through ERKMAPK/c-Myc signaling. Oncol
Rep. 37:1100–1106. 2017.PubMed/NCBI
|
|
7
|
Davis RJ: Transcriptional regulation by
MAP kinases. Mol Reprod Dev. 42:459–467. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sipos F, Firneisz G and Műzes G:
Therapeutic aspects of c-MYC signaling in inflammatory and
cancerous colonic diseases. World J Gastroenterol. 22:7938–7950.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang C, Tai Y, Lisanti MP and Liao DJ:
c-Myc induction of programmed cell death may contribute to
carcinogenesis: A perspective inspired by several concepts of
chemical carcinogenesis. Cancer Biol Ther. 11:615–626. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Branca M, Ciotti M, Santini D, Bonito LD,
Benedetto A, Giorgi C, Paba P, Favalli C, Costa S, Agarossi A, et
al: Activation of the ERK/MAP kinase pathway in cervical
intraepithelial neoplasia is related to grade of the lesion but not
to high-risk human papillomavirus, virus clearance, or prognosis in
cervical cancer. Am J Clin Pathol. 122:902–911. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang J, Zhang Y, Liu S, Zhang Q, Wang Y,
Tong L, Chen X, Ji Y, Shang Q, Xu B, et al: Metadherin confers
chemoresistance of cervical cancer cells by inducing autophagy and
activating ERK/NF-κB pathway. Tumour Biol. 34:2433–2440. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Narayan G, Xie D, Ishdorj G, Scotto L,
Mansukhani M, Pothuri B, Wright JD, Kaufmann AM, Schneider A,
Arias-Pulido H and Murty VV: Epigenetic inactivation of TRAIL decoy
receptors at 8p12-21.3 commonly deleted region confers sensitivity
to Apo2L/trail-Cisplatin combination therapy in cervical cancer.
Genes Chromosomes Cancer. 55:177–189. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Umayahara K, Takekuma M, Hirashima Y, Noda
SE, Ohno T, Miyagi E, Hirahara F, Hirata E, Kondo E, Tabata T, et
al: Phase II study of concurrent chemoradiotherapy with weekly
cisplatin and paclitaxel in patients with locally advanced uterine
cervical cancer: The JACCRO GY-01 trial. Gynecol Oncol.
140:253–258. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu H, Dong Y, Gao Y, Du Z, Wang Y, Cheng
P, Chen A and Huang H: The Fascinating Effects of Baicalein on
Cancer: A Review. Int J Mol Sci. 17:pii: E1681. 2016. View Article : Google Scholar
|
|
15
|
Guo Z, Hu X, Xing Z, Xing R, Lv R, Cheng
X, Su J, Zhou Z, Xu Z, Nilsson S and Liu Z: Baicalein inhibits
prostate cancer cell growth and metastasis via the
caveolin-1/AKT/mTOR pathway. Mol Cell Biochem. 406:111–119. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han Z, Zhu S, Han X, Wang Z, Wu S and
Zheng R: Baicalein inhibits hepatocellular carcinoma cells through
suppressing the expression of CD24. Int Immunopharmacol.
29:416–422. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Peng Y, Guo C, Yang Y, Li F, Zhang Y,
Jiang B and Li Q: Baicalein induces apoptosis of human cervical
cancer HeLa cells in vitro. Mol Med Rep. 11:2129–2134.
2015.PubMed/NCBI
|
|
18
|
Aryal P, Kim K, Park PH, Ham S, Cho J and
Song K: Baicalein induces autophagic cell death through AMPK/ULK1
activation and downregulation of mTORC1 complex components in human
cancer cells. FEBS J. 281:4644–4658. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rose HM, Stuiver M, Thongwichian R,
Theillet FX, Feller SM and Selenko P: Quantitative NMR analysis of
Erk activity and inhibition by U0126 in a panel of patient-derived
colorectal cancer cell lines. Biochim Biophys Acta. 1834:1396–1401.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo M, Wei H, Hu J, Sun S, Long J and Wang
X: U0126 inhibits pancreatic cancer progression via the KRAS
signaling pathway in a zebrafish xenotransplantation model. Oncol
Rep. 34:699–706. 2015.PubMed/NCBI
|
|
21
|
Lodi A, Woods SM and Ronen SM: Treatment
with the MEK inhibitor U0126 induces decreased hyperpolarized
pyruvate to lactate conversion in breast, but not prostate, cancer
cells. NMR Biomed. 26:299–306. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gebäck T, Schulz MM, Koumoutsakos P and
Detmar M: TScratch: A novel and simple software tool for automated
analysis of monolayer wound healing assays. Biotechniques.
46:265–274. 2009.PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang YF, Xu YL, Tang ZH, Li T, Zhang LL,
Chen X, Lu JH, Leung CH, Ma DL, Qiang WA, et al: Baicalein induces
beclin 1- and extracellular signal-regulated kinase-dependent
autophagy in ovarian cancer cells. Am J Chin Med. 45:123–136. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Herfs M, Yamamoto Y, Laury A, Wang X,
Nucci MR, McLaughlin-Drubin ME, Münger K, Feldman S, McKeon FD,
Xian W and Crum CP: A discrete population of squamocolumnar
junction cells implicated in the pathogenesis of cervical cancer.
Proc Natl Acad Sci USA. 109:10516–10521. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Trunk MJ, Wentzensen N and von Knebel
Doeberitz M: Molecular pathogenesis of cervical cancer and its
first steps. Pathologe. 26:283–290. 2005.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim DH, Hossain MA, Kang YJ, Jang JY, Lee
YJ, Im E, Yoon JH, Kim HS, Chung HY and Kim ND: Baicalein, an
active component of Scutellaria baicalensis Georgi, induces
apoptosis in human colon cancer cells and prevents AOM/DSS-induced
colon cancer in mice. Int J Oncol. 43:1652–1658. 2013.PubMed/NCBI
|
|
28
|
Li HL, Zhang S, Wang Y, Liang RR, Li J, An
P, Wang ZM, Yang J and Li ZF: Baicalein induces apoptosis via a
mitochondrial-dependent caspase activation pathway in T24 bladder
cancer cells. Mol Med Rep. 7:266–270. 2013.PubMed/NCBI
|
|
29
|
Lin YT, Yang JS, Lin HJ, Tan TW, Tang NY,
Chaing JH, Chang YH, Lu HF and Chung JG: Baicalein induces
apoptosis in SCC-4 human tongue cancer cells via a Ca2+-dependent
mitochondrial pathway. In Vivo. 21:1053–1058. 2007.PubMed/NCBI
|
|
30
|
Liu Z, Ren L, Liu C, Xia T, Zha X and Wang
S: Phenformin induces cell cycle change, apoptosis, and
mesenchymal-epithelial transition and regulates the
AMPK/mTOR/p70s6k and MAPK/ERK pathways in breast cancer cells. PLoS
One. 10:e01312072015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
de Tomaso Portaz AC, Caimi GR, Sánchez M,
Chiappini F, Randi AS, de Kleiman Pisarev DL and Alvarez L:
Hexachlorobenzene induces cell proliferation, and aryl hydrocarbon
receptor expression (AhR) in rat liver preneoplastic foci and in
the human hepatoma cell line HepG2. AhR is a mediator of ERK1/2
signaling, and cell cycle regulation in HCB-treated HepG2 cells.
Toxicology. 336:36–47. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Green DR and Llambi F: Cell Death
Signaling. Cold Spring Harb Perspect Biol. 7:pii: a006080. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Savitskaya MA and Onishchenko GE:
Mechanisms of apoptosis. Biochemistry (Mosc). 80:1393–1405. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bortner CD, Scoltock AB, Cain DW and
Cidlowski JA: T-cell development of resistance to apoptosis is
driven by a metabolic shift in carbon source and altered activation
of death pathways. Cell Death Differ. 23:889–902. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Iranpour M, Moghadam AR, Yazdi M, Ande SR,
Alizadeh J, Wiechec E, Lindsay R, Drebot M, Coombs KM and Ghavami
S: Apoptosis, autophagy and unfolded protein response pathways in
Arbovirus replication and pathogenesis. Expert Rev Mol Med.
18:e12016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Casagrande N, De Paoli M, Celegato M,
Borghese C, Mongiat M, Colombatti A and Aldinucci D: Preclinical
evaluation of a new liposomal formulation of cisplatin, lipoplatin,
to treat cisplatin-resistant cervical cancer. Gynecol Oncol.
131:744–752. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cetina L, González-Enciso A, Cantú D,
Coronel J, Pérez-Montiel D, Hinojosa J, Serrano A, Rivera L,
Poitevin A, Mota A, et al: Brachytherapy versus radical
hysterectomy after external beam chemoradiation with gemcitabine
plus cisplatin: A randomized, phase III study in IB2-IIB cervical
cancer patients. Ann Oncol. 24:2043–2047. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tjalma WA, Weyler JJ, Bogers JJ,
Pollefliet C, Baay M, Goovaerts GC, Vermorken JB, van Dam PA, van
Marck EA and Buytaert PM: The importance of biological factors
(bcl-2, bax, p53, PCNA, MI, HPV and angiogenesis) in invasive
cervical cancer. Eur J Obstet Gynecol Reprod Biol. 97:223–230.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhao LW, Zhong XH, Yang SY, Zhang YZ and
Yang NJ: Inotodiol inhabits proliferation and induces apoptosis
through modulating expression of cyclinE, p27, bcl-2, and bax in
human cervical cancer HeLa cells. Asian Pac J Cancer Prev.
15:3195–3199. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Alečković M and Kang Y: Welcoming Treat:
Astrocyte-derived exosomes induce pten suppression to foster brain
metastasis. Cancer Cell. 28:554–556. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
von Karstedt S, Conti A, Nobis M,
Montinaro A, Hartwig T, Lemke J, Legler K, Annewanter F, Campbell
AD and Taraborrelli L: Cancer cell-autonomous TRAIL-R signaling
promotes KRAS-driven cancer progression, invasion, and metastasis.
Cancer Cell. 27:561–573. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Che YL, Luo SJ, Li G, Cheng M, Gao YM, Li
XM, Dai JM, He H, Wang J, Peng HJ, et al: The C3G/Rap1 pathway
promotes secretion of MMP-2 and MMP-9 and is involved in serous
ovarian cancer metastasis. Cancer Lett. 359:241–249. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang C, Ma HX, Jin MS, Zou YB, Teng YL,
Tian Z, Wang HY, Wang YP and Duan XM: Association of matrix
metalloproteinase (MMP)-2 and -9 expression with
extra-gastrointestinal stromal tumor metastasis. Asian Pac J Cancer
Prev. 15:4187–4192. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Avolio C, Ruggieri M, Giuliani F, Liuzzi
GM, Leante R, Riccio P, Livrea P and Trojano M: Serum MMP-2 and
MMP-9 are elevated in different multiple sclerosis subtypes. J
Neuroimmunol. 136:46–53. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Fatar M, Stroick M, Steffens M, Senn E,
Reuter B, Bukow S, Griebe M, Alonso A, Lichtner P, Bugert P, et al:
Single-nucleotide polymorphisms of MMP-2 gene in stroke subtypes.
Cerebrovasc Dis. 26:113–119. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Alves AC, Albertini R, dos Santos SA,
Leal-Junior EC, Santana E, Serra AJ, Silva JA Jr and de Carvalho
Pde T: Effect of low-level laser therapy on metalloproteinase MMP-2
and MMP-9 production and percentage of collagen types I and III in
a papain cartilage injury model. Lasers Med Sci. 29:911–919.
2014.PubMed/NCBI
|
|
47
|
Tunik S, Ayaz E, Akpolat V, Nergiz Y, Isen
K, Celik MS and Seker U: Effects of pulsed and sinusoidal
electromagnetic fields on MMP-2, MMP-9, collagen type IV and
E-cadherin expression levels in the rat kidney: An
immunohistochemical study. Anal Quant Cytopathol Histpathol.
35:253–260. 2013.PubMed/NCBI
|
|
48
|
Roomi MW, Monterrey JC, Kalinovsky T, Rath
M and Niedzwiecki A: In vitro modulation of MMP-2 and MMP-9 in
human cervical and ovarian cancer cell lines by cytokines, inducers
and inhibitors. Oncol Rep. 23:605–614. 2010.PubMed/NCBI
|
|
49
|
Fernandes T, de Angelo-Andrade LA, Morais
SS, Pinto GA, Chagas CA, Maria-Engler SS and Zeferino LC: Stromal
cells play a role in cervical cancer progression mediated by MMP-2
protein. Eur J Gynaecol Oncol. 29:341–344. 2008.PubMed/NCBI
|
